Alternative splicing generates HER2 isoform diversity underlying antibody–drug conjugate resistance in breast cancer

Journal:
Genome Research
Published:
DOI:
10.1101/gr.280304.124
Affiliations:
4
Authors:
8
Go to article
Institutions Authors Share
Hospital Sírio-Libanês, Brazil
5.000000
 0.63
University of Manitoba, Canada
1.000000
 0.13
University of São Paulo (USP), Brazil
1.000000
 0.13
University of Wisconsin-Madison (UW-Madison), United States of America (USA)
1.000000
 0.13
Interested in Oncology and Carcinogenesis?